Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYCancer reports (Hoboken, N.J.)

Clinical Markers of Vulnerability for Bleeding in Men With Prostate Cancer and Antithrombotic Treatment

  • Linda Björkhem‐Bergman1
  • Christel Hedman2
  • Máté Szilcz1
  • Gabriella Frisk1
  1. 1Karolinska Institutet
  2. 2Stockholms Sjukhems R&D Department
Read full textPDFCite

Related

  1. High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention: How to Choose the Optimal Antithrombotic Therapy, Its Duration and the Right Stent; A Comprehensive Review of the Current Literature and Proposed Treatment Algorithms
    Charalampos Kakderis, Matthaios Didagelos, Thomas Zegkos +11
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefEurope PMC
  2. Vulnerability index impacts distribution of prostate cancer clinical trials in the United States.
    Vitor Abreu de Goes, Benjamin Mercier, Yu Jun Li +22
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  3. A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.
    S. Sridhar, K. Mohan, S. Kizhake +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Long-term outcomes of antithrombotic treatment for retinal vein occlusion
    Davide Sacchet, Corrado Lodigiani, Clara Sacco +7
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  5. [Clinical characteristics and in-hospital outcomes of patients receiving antithrombotic therapy in a cardiac intensive care unit in sub-Saharan Africa: a retrospective comparative study at the Cardiology Institute of Abidjan].
    Christelle Gbassi, Florent Koffi, Cédric Kee +10
    The Pan African medical journalPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{bjorkhembergman2026clinical,
  title = {{Clinical Markers of Vulnerability for Bleeding in Men With Prostate Cancer and Antithrombotic Treatment}},
  author = {Linda Björkhem‐Bergman and Christel Hedman and Máté Szilcz and Gabriella Frisk},
  journal = {Cancer reports (Hoboken, N.J.)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13659391},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Clinical Markers of Vulnerability for Bleeding in Men With Prostate Cancer and Antithrombotic Treatment
AU  - Linda Björkhem‐Bergman
AU  - Christel Hedman
AU  - Máté Szilcz
AU  - Gabriella Frisk
PY  - 2026
DA  - 2026/10/01
JO  - Cancer reports (Hoboken, N.J.)
UR  - https://europepmc.org/article/PMC/PMC13659391
SN  - 2573-8348
ER  -